(Q48071032)

English

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew M. Chanen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christopher G Davey

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Patrick McGorry

21

object named as

Patrick McGorry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

object named as

Olivia M Dean

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Amelia L Quinn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Melissa Kerr

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Seetal Dodd

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Aswin Ratheesh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Paul Amminger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mark Phelan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Amber Williams

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrew Mackinnon

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Francesco Giorlando

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Melissa O'Shea

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Miriam R Schäfer

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Edward Mullen

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

5 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

45-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26542332%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Birth cohort increases in psychopathology among young Americans, 1938-2007: A cross-temporal meta-analysis of the MMPI.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Mental health, educational, and social role outcomes of adolescents with depression

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Integrating the monoamine, neurotrophin and cytokine hypotheses of depression--a central role for the serotonin transporter?

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Association of high-sensitivity C-reactive protein with de novo major depression.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Drug addiction as a pathology of staged neuroplasticity

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

IL-6 levels decrease with SSRI treatment in patients with major depression.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Low plasma vitamin E levels in major depression: diet or disease?

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Newer generation antidepressants for depressive disorders in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

A brief measure for assessing generalized anxiety disorder: the GAD-7.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Validation of two global impression questionnaires for incontinence

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Negative problem orientation (Part I): psychometric properties of a new measure.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Sensitivity and specificity of a new bipolar spectrum diagnostic scale

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Confidence intervals for the number needed to treat

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Handling missing data in randomized experiments with noncompliance

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Depressed Adolescents Grown Up

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1111%2FEIP.12280

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48071032&oldid=2101989051"